Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Esophageal Neoplasms × CP protocol × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcopenia 1 Ovarian Neoplasms 1 Malnutrition 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Dysgeusia 1

Interventions

Paclitaxel 7 Cisplatin 5 Radiation 4 Carboplatin 4 tislelizumab 3 Surgical Procedures, Operative 3 Radiotherapy 3 Immune Checkpoint Inhibitors 3 Capecitabine 3 camrelizumab 2 Platinum Compounds 2 Endoscopic Mucosal Resection 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 nedaplatin 1 Tranexamic Acid 1 Thalidomide 1 TP protocol 1 Stents 1 Standard of Care 1 Oxaliplatin 1 Nutrition Assessment 1 Neoadjuvant Therapy 1 Muscle Stretching Exercises 1 Indocyanine Green 1 Heart Rate 1 Fluorouracil 1 Exercise 1 Epinephrine 1 Elective Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡